Shares of Watertown biotech Tetraphase Pharmaceuticals Inc. fell Wednesday after the company disclosed plans to sell 3.5 million shares in a public stock offering. The clinical-stage company, a developer of antibiotics, would raise about $118 million with This afternoon Nature Biotechnology published its annual review of the “some of the best that academic research had to offer the startup world in 2014.” The article, in the March 2015 issue, covers the editors’ selections of the top startups – and (Bloomberg) -- At a state-of-the-art facility in Thousand Oaks, California, drugmaker Amgen Inc. is perfecting the art of copying others. The 25,000-square-foot (2,300-square-meter) plant is filled with stainless steel tanks that can hold as much as 2,000 “It was one of the classes offered at the campus closest to me,” Neill said. “I was looking at different things. … Biotech just seemed like the right fit for me. So that’s what I went into, and it’s been great.” While studying at Biotech's days of unfettered optimism may be numbered. Since 2011, money has flowed almost nonstop into the industry as investors buy into the promise of new drugs. Signs are increasingly pointing toward an end to the boom. One key measure of investor Vapogenix, a Houston biotech that aims to build a better treatment for skin pain, has completed a $5.1 million Series B funding round—and is already looking at raising additional capital later this year. The B round was led by Switzerland-based Pamoja .
WEST DES MOINES, IA--(Marketwired - Mar 10, 2015) - Spotlight Innovation Inc. (OTCQB: STLT) announces that its subsidiary Celtic Biotech Iowa, Inc., entered into an exclusive, world-wide (excluding China) license agreement to develop and market a patent The U.S. Food & Drug Administration approved the first generic version of a biotech drug for domestic sale Friday, hours after Colorado state legislators wrestled with how to let pharmacists handle cheaper biotech drug knockoffs. Colorado is among several Anthony J. Alfidi is the founder and CEO of Alfidi Capital, a research firm in San Francisco, California. Alfidi Capital publishes free financial research with honesty and humor. Mr. Alfidi holds a Bachelor's degree in human resource management from the Ben Benoy: In 1965, one of the co-founder’s of Intel Corporation, Gordon E. Moore, wrote an article in Electronics Magazine on a trend he had been watching for several years in integrated circuit (chip) manufacturing. Gordon observed that over the .
- biotech news Battle in India - Wall Street Journal - http://news.google.com/news 80 x 80 · 3 kB · jpeg
- biotech news Found on cancernetwork.com 150 x 198 · 14 kB · jpeg
- biotech news f576f23a77e05a079b7da792ae50321d. 109 x 90 · 5 kB · jpeg
- biotech news the top spot as the most sustainable company in the “Biotechnology 150 x 150 · 3 kB · jpeg
- biotech news pharmaceutical industry. - See more at: http://globalmilling.com 150 x 150 · 7 kB · jpeg
- biotech news Nutraferma, a biotech solutions company, has named Dr Peter KS Chu as 150 x 150 · 3 kB · jpeg
- biotech news b873e8493cc8c773ba72768761c16555. 175 x 150 · 3 kB · jpeg
- biotech news Rapamycin Holdings Hopes To Exploit Commercial Potential Of UT Health 108 x 150 · 6 kB · jpeg
- biotech news 8af60b2e40ad9970a36847f725325b1d. 175 x 150 · 3 kB · jpeg
- biotech news com/dropshipping-news-aus-amerika/wholesale-pharmaceutical-drugs.html 75 x 75 · 3 kB · jpeg
biotech news Image Gallery
No comments:
Post a Comment